| Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study B Coiffier, C Haioun, N Ketterer, A Engert, H Tilly, D Ma, P Johnson, ... Blood, The Journal of the American Society of Hematology 92 (6), 1927-1932, 1998 | 1293 | 1998 |
| PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin … P Borchmann, H Goergen, C Kobe, A Lohri, R Greil, DA Eichenauer, ... The Lancet 390 (10114), 2790-2802, 2017 | 363 | 2017 |
| 2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party M Heuser, SD Freeman, GJ Ossenkoppele, F Buccisano, CS Hourigan, ... Blood, The Journal of the American Society of Hematology 138 (26), 2753-2767, 2021 | 344 | 2021 |
| The AML1-ETO fusion gene and the FLT3 length mutation collaborate in inducing acute leukemia in mice C Schessl, VPS Rawat, M Cusan, A Deshpande, TM Kohl, PM Rosten, ... The Journal of clinical investigation 115 (8), 2159-2168, 2005 | 301 | 2005 |
| Mitochondria targeted protein-ruthenium photosensitizer for efficient photodynamic applications S Chakrabortty, BK Agrawalla, A Stumper, NM Vegi, S Fischer, ... Journal of the American Chemical Society 139 (6), 2512-2519, 2017 | 278 | 2017 |
| Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations D Haase, M Feuring-Buske, S Konemann, C Fonatsch, C Troff, W Verbeek, ... | 207 | 1995 |
| Deregulated expression of HOXB4 enhances the primitive growth activity of human hematopoietic cells C Buske, M Feuring-Buske, C Abramovich, K Spiekermann, CJ Eaves, ... Blood, The Journal of the American Society of Hematology 100 (3), 862-868, 2002 | 200 | 2002 |
| A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors M Feuring-Buske, AE Frankel, RL Alexander, B Gerhard, DE Hogge Cancer research 62 (6), 1730-1736, 2002 | 184 | 2002 |
| Induction of acute myeloid leukemia in mice by the human leukemia-specific fusion gene NUP98-HOXD13 in concert with Meis1 N Pineault, C Buske, M Feuring-Buske, C Abramovich, P Rosten, ... Blood 101 (11), 4529-4538, 2003 | 175 | 2003 |
| Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34+CD38− progenitor cells from patients with acute myeloid leukemia M Feuring-Buske, DE Hogge Blood, The Journal of the American Society of Hematology 97 (12), 3882-3889, 2001 | 169 | 2001 |
| Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo C Buske, M Feuring-Buske, J Antonchuk, P Rosten, DE Hogge, CJ Eaves, ... Blood, The Journal of the American Society of Hematology 97 (8), 2286-2292, 2001 | 159 | 2001 |
| Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia AJ Deshpande, M Cusan, VPS Rawat, H Reuter, A Krause, C Pott, ... Cancer cell 10 (5), 363-374, 2006 | 154 | 2006 |
| A novel role for Lef-1, a central transcription mediator of Wnt signaling, in leukemogenesis K Petropoulos, N Arseni, C Schessl, CR Stadler, VPS Rawat, ... The Journal of experimental medicine 205 (3), 515-522, 2008 | 152 | 2008 |
| Improved engraftment of human acute myeloid leukemia progenitor cells in beta 2-microglobulin-deficient NOD/SCID mice and in NOD/SCID mice transgenic for human growth factors M Feuring-Buske, B Gerhard, J Cashman, RK Humphries, CJ Eaves, ... Leukemia 17 (4), 760-763, 2003 | 149 | 2003 |
| Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML) F Schneider, E Hoster, S Schneider, A Dufour, T Benthaus, PM Kakadia, ... Annals of hematology 91, 9-18, 2012 | 144 | 2012 |
| Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t (12; 13)(p13; q12) acute myeloid leukemia VPS Rawat, M Cusan, A Deshpande, W Hiddemann, ... Proceedings of the National Academy of Sciences 101 (3), 817-822, 2004 | 137 | 2004 |
| IDEC-C2B8 (Rituximab) anti-CD20 antibody treatment in relapsed advanced-stage follicular lymphomas: results of a phase-II study of the German Low-Grade Lymphoma Study Group M Feuring-Buske, M Kneba, M Unterhalt, A Engert, M Gramatzki, E Hiller, ... Annals of hematology 79, 493-500, 2000 | 120 | 2000 |
| Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia F Pastore, A Dufour, T Benthaus, KH Metzeler, KS Maharry, S Schneider, ... Journal of Clinical Oncology 32 (15), 1586, 2014 | 113 | 2014 |
| NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic … F Schneider, E Hoster, M Unterhalt, S Schneider, A Dufour, T Benthaus, ... Blood, The Journal of the American Society of Hematology 113 (21), 5250-5253, 2009 | 98 | 2009 |
| Overexpression of CDX2 perturbs HOX gene expression in murine progenitors depending on its N-terminal domain and is closely correlated with deregulated HOX gene expression in … VPS Rawat, S Thoene, VM Naidu, N Arseni, B Heilmeier, K Metzeler, ... Blood, The Journal of the American Society of Hematology 111 (1), 309-319, 2008 | 94 | 2008 |
